KUTSU SSH COMMUNICATIONS SECURITY OYJ:N Q2/2019-OSAVUOSIKATSAUSTA KOSKEVAAN TIEDOTUSTILAISUUTEEN
05 juil. 2019 07h12 HE
|
SSH Communications Security Oyj
KUTSU SSH COMMUNICATIONS SECURITY OYJ:N Q2/2019-OSAVUOSIKATSAUSTA KOSKEVAAN TIEDOTUSTILAISUUTEEN SSH Communications Securityn Q2/2019-osavuosikatsaus julkaistaan keskiviikkona 17.7.2019...
INVITATION TO A PRESS CONFERENCE ON SSH COMMUNICATIONS SECURITY’S Q2/2019 INTERIM REPORT
05 juil. 2019 07h12 HE
|
SSH Communications Security Corporation
INVITATION TO A PRESS CONFERENCE ON SSH COMMUNICATIONS SECURITY’S Q2/2019 INTERIM REPORT SSH Communications Security´s Q2/2019 interim report will be published on Wednesday, July 17th,...
Delårsrapport for 1. januar - 31. marts 2019 for FirstFarms A/S
28 mai 2019 06h10 HE
|
FirstFarms A/S
Delårsrapport for 1. januar – 31. marts 2019 for FirstFarms A/S ResuméBestyrelsen og direktionen i FirstFarms A/S har d.d. behandlet og godkendt det ureviderede delårsregnskab for perioden 1....
Interim financial report for 1 January - 31 March 2019 for FirstFarms A/S
28 mai 2019 06h10 HE
|
FirstFarms A/S
Interim financial report for 1 January – 31 March 2019 for FirstFarms A/S SummaryThe Board of Directors and Management of FirstFarms A/S have today reviewed and adopted the un-audited interim...
Goodvalley maintained strong operational performance
27 mai 2019 03h52 HE
|
Goodvalley A/S
Goodvalley maintained strong operational performance and continued to improve production efficiency in the face of challenging market conditions in Q1 2019. While financial performance in the...
AroCell AB (publ) Delårsrapport 1 januari – 31 mars 2019
16 mai 2019 02h00 HE
|
AroCell AB
VD-ORD ”Biomarkörer kommer spela en allt större roll i hur vi identifierar och följer upp behandlingar av patienter med cancer de kommande åren. Utvecklingen kring ökad individanpassning drivs av...
AroCell AB (publ) Interim Report 1st January to 31st March 2019
16 mai 2019 02h00 HE
|
AroCell AB
Word from the CEO “Biomarkers will play an increasingly important role in how we identify and follow up treatments for patients with cancer in the coming years. The development of an increased...
Hexatronic Group AB (publ) Interim Report 1 January – 31 March 2019
03 mai 2019 02h00 HE
|
Hexatronic Group AB
Hexatronic Group AB (publ) Interim Report 1 January – 31 March 2019 The quarter (1 January – 31 March 2019) Net sales amounted to MSEK 421.1 (339.2), which represents 24% (16%) growth during the...
Hexatronic Group AB (publ) Delårsrapport 1 januari – 31 mars 2019
03 mai 2019 02h00 HE
|
Hexatronic Group AB
Hexatronic Group AB (publ) Delårsrapport 1 januari – 31 mars 2019 Kvartalet (1 januari till 31 mars 2019) Nettoomsättningen uppgick till 421,1 MSEK (339,2) vilket motsvarar 24 % (16 %)...
Net Insight AB: Net Insight Delårsrapport Januari - mars 2019
25 avr. 2019 02h45 HE
|
Net Insight AB
Citat från verkställande direktör Henrik Sund: ”Ett mycket viktigt Sye-avtal med ett amerikanskt Fortune 500-företag.” Första kvartalet 2019 Nettoomsättningen uppgick till 111,3 MSEK (110,5), en...